Clinical trial
Safety and Immunogenicity of Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: a Four-arm, Double-blind, Non-inferiority Trial
NCT05767606 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: a Four-arm, Double-blind, Non-inferiority Trial
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2023
- Completion date
- August 31, 2023
- Enrollment
- 256 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.